Donanemab
Donanemab Shows Significant Advance in Alzheimerās Treatment
SG Tylor
Source – Eli Lilly The full data from Eli Lilly’s TRAILBLAZER-ALZ 2 trial of the amyloid drug donanemab has validated ...
Source – Eli Lilly The full data from Eli Lilly’s TRAILBLAZER-ALZ 2 trial of the amyloid drug donanemab has validated ...